PPARγ inhibitors attenuate the pro-inflammatory effects of M1 TAMs and suppress the secretion of pro-tumorigenic cytokines by M2 macrophages, further inhibiting tumor progression (92, 93). This evidence concerns the gene PPARG and neoplasm.